Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI
· Real-Time Price · USD
14.71
0.25 (1.73%)
At close: Aug 15, 2025, 3:59 PM
14.60
-0.71%
After-hours: Aug 15, 2025, 07:56 PM EDT
Denali Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -124.12M | -132.97M | -114.75M | -107.19M | -99.03M | -101.8M | -119.47M | -99.35M | 183.38M | -109.78M | -98.68M | -103.3M | -58.79M | -65.22M | -75.26M | -84.59M | -60.69M | -70.04M |
Depreciation & Amortization | 3.96M | 3.21M | 1.85M | 2.27M | 1.94M | 2.16M | 2.18M | 2.22M | 2.29M | 10.05M | 4.09M | 2.14M | 2.07M | 2.08M | 2.09M | 2.19M | 2.2M | 2.11M |
Stock-Based Compensation | 25.39M | 25.16M | 25.08M | 24.86M | 25.1M | 27.84M | 25.99M | 27.46M | 26.57M | 28.08M | 25.19M | 24.58M | 23.94M | 26.14M | 22.09M | 21M | 21.14M | 21.03M |
Other Working Capital | 19.29M | -19.29M | 9.27M | 28.34M | -12.05M | -16.45M | 7.93M | -447K | -317.72M | 17.88M | 2.37M | 19.14M | -10.61M | -37.2M | -15.98M | 17.31M | -21.02M | -4.43M |
Other Non-Cash Items | -2.46M | -4.94M | -6.45M | -3.04M | 14.02M | 5.52M | 19.23M | -957K | -928K | -8.73M | -3.92M | -1.51M | -344K | 844K | -783K | -782K | -726K | -693K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -32.42M | -12.32M | -11.53M | n/a | n/a | n/a | n/a | n/a | 2.43M | 2.66M | 2.5M | 1.16M |
Change in Working Capital | 21.93M | -21.93M | 10.55M | 23.97M | -8.16M | -15.81M | 5.85M | -4.41M | -312.95M | 21.58M | 655K | 21.04M | -9.77M | -35.96M | -16.06M | 18.09M | -18.64M | -3.8M |
Operating Cash Flow | -75.3M | -131.47M | -83.72M | -59.14M | -91.22M | -113.62M | -98.66M | -87.36M | -113.17M | -58.8M | -72.66M | -57.05M | -42.9M | -72.11M | -65.49M | -41.43M | -54.22M | -50.24M |
Capital Expenditures | -4.28M | -5.08M | -5.09M | -3.88M | -4.79M | -2.15M | -2.23M | -2.07M | -5.85M | -2.79M | -4.85M | -6.05M | -2.89M | -4.04M | -3.05M | -1.88M | -772K | -2.8M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -75.28M | -102.98M | -173.92M | 89.93M | 122.71M | -21.47M | -91.52M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -137.93M | -173.7M | -100.46M | -121.64M | -834.16M | -413.72M | -498.14M | -378.13M | -523.71M | -486.71M | -122.87M | -141.12M | -364.34M | -231.45M | -344.19M | -384.19M | -463.11M |
Sales Maturities Of Investments | 162.21M | 161.75M | 351M | 198M | 225M | 383.12M | 489M | 601.12M | 552.04M | 433.79M | 364M | 144.34M | 232.65M | 250.5M | 193.75M | 293.06M | 482.5M | 440.5M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 103.36M | -451.04M | 75.28M | 102.98M | 173.92M | -89.93M | -122.71M | 21.47M | 91.52M | -113.84M | -37.7M | -51.13M | 98.31M | -22.61M |
Investing Cash Flow | 157.94M | 18.75M | 172.21M | 93.66M | 98.57M | -453.19M | 73.05M | 100.91M | 168.07M | -92.72M | -127.56M | 15.42M | 88.63M | -117.88M | -40.75M | -53.01M | 97.54M | -25.41M |
Debt Repayment | n/a | -4.36M | -8.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.62M | 595K | 4.16M | -18.56M | 6.76M | 1.02M | 4.71M | 2.49M | 9.02M | 1.6M | 299.65M | 5.15M | 4.4M | 1.46M | 5.17M | 3.31M | 7.04M | 3.82M |
Financial Cash Flow | 1.62M | -3.76M | -4.17M | -18.56M | 6.76M | 500.27M | 4.71M | 2.49M | 9.02M | 1.6M | 299.65M | 5.15M | 4.4M | 1.46M | 5.17M | 3.31M | 7.04M | 3.82M |
Net Cash Flow | 84.26M | -116.48M | 84.32M | 15.96M | 14.11M | -66.53M | -20.91M | 16.04M | 63.92M | -149.91M | 99.43M | -36.47M | 50.13M | -188.52M | -101.08M | -91.13M | 50.36M | -71.82M |
Free Cash Flow | -79.58M | -136.55M | -88.81M | -63.02M | -96.01M | -115.77M | -100.89M | -89.43M | -119.02M | -61.59M | -77.51M | -63.1M | -45.79M | -76.15M | -68.55M | -43.31M | -54.99M | -53.04M |